Cargando…

Cognitive Impairment in Genetic Parkinson's Disease

Cognitive impairment is common in idiopathic Parkinson's disease (PD). Knowledge of the contribution of genetics to cognition in PD is increasing in the last decades. Monogenic forms of genetic PD show distinct cognitive profiles and rate of cognitive decline progression. Cognitive impairment i...

Descripción completa

Detalles Bibliográficos
Autores principales: Planas-Ballvé, A., Vilas, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739522/
https://www.ncbi.nlm.nih.gov/pubmed/35003622
http://dx.doi.org/10.1155/2021/8610285
_version_ 1784629118274371584
author Planas-Ballvé, A.
Vilas, D.
author_facet Planas-Ballvé, A.
Vilas, D.
author_sort Planas-Ballvé, A.
collection PubMed
description Cognitive impairment is common in idiopathic Parkinson's disease (PD). Knowledge of the contribution of genetics to cognition in PD is increasing in the last decades. Monogenic forms of genetic PD show distinct cognitive profiles and rate of cognitive decline progression. Cognitive impairment is higher in GBA- and SNCA-associated PD, lower in Parkin- and PINK1-PD, and possibly milder in LRRK2-PD. In this review, we summarize data regarding cognitive function on clinical studies, neuroimaging, and biological markers of cognitive decline in autosomal dominant PD linked to mutations in LRRK2 and SNCA, autosomal recessive PD linked to Parkin and PINK1, and also PD linked to GBA mutations.
format Online
Article
Text
id pubmed-8739522
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-87395222022-01-08 Cognitive Impairment in Genetic Parkinson's Disease Planas-Ballvé, A. Vilas, D. Parkinsons Dis Review Article Cognitive impairment is common in idiopathic Parkinson's disease (PD). Knowledge of the contribution of genetics to cognition in PD is increasing in the last decades. Monogenic forms of genetic PD show distinct cognitive profiles and rate of cognitive decline progression. Cognitive impairment is higher in GBA- and SNCA-associated PD, lower in Parkin- and PINK1-PD, and possibly milder in LRRK2-PD. In this review, we summarize data regarding cognitive function on clinical studies, neuroimaging, and biological markers of cognitive decline in autosomal dominant PD linked to mutations in LRRK2 and SNCA, autosomal recessive PD linked to Parkin and PINK1, and also PD linked to GBA mutations. Hindawi 2021-12-30 /pmc/articles/PMC8739522/ /pubmed/35003622 http://dx.doi.org/10.1155/2021/8610285 Text en Copyright © 2021 A. Planas-Ballvé and D. Vilas. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Planas-Ballvé, A.
Vilas, D.
Cognitive Impairment in Genetic Parkinson's Disease
title Cognitive Impairment in Genetic Parkinson's Disease
title_full Cognitive Impairment in Genetic Parkinson's Disease
title_fullStr Cognitive Impairment in Genetic Parkinson's Disease
title_full_unstemmed Cognitive Impairment in Genetic Parkinson's Disease
title_short Cognitive Impairment in Genetic Parkinson's Disease
title_sort cognitive impairment in genetic parkinson's disease
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739522/
https://www.ncbi.nlm.nih.gov/pubmed/35003622
http://dx.doi.org/10.1155/2021/8610285
work_keys_str_mv AT planasballvea cognitiveimpairmentingeneticparkinsonsdisease
AT vilasd cognitiveimpairmentingeneticparkinsonsdisease